The Relationship between the Antitumor Effect of the IL-12 Gene Therapy and the Expression of Th1 Cytokines in an HPV16-Positive Murine Tumor Model

Abstract

Objective. The goal of the present study was to investigate the effect of IL-12 expressed in plasmid on the Th1 cytokine profile in an experimental HPV16-positive murine tumor model and the association with the IL-12's antitumor effect. Methods. Mice were injected with BMK-16/myc cells to establish HPV16-positive tumor and then pNGVL3-mIL-12 plasmid; pcDNA3 plasmid or PBS was injected directly into tumor site. The antitumor effect of the treatment was evaluated and the cytokines expression profile in each tumor tissue was analyzed. Results. Treatment with pNGVL3-mIL-12 plasmid had a significant antitumor effect, and a Th2-Th3-type cytokines prolife was detected in the murine tumor model with expression of the cytokines IL-10, IL-4, and TGF-β1. However, after the tumor was treated with three intratumoral injections of plasmid containing IL-12 cDNA, it showed a cytokine profile associated with Th1 with expression of IL-2, IL-12, and IFN-γ cytokines and reduced expression of IL-10, IL-4, and TGF-β1. Conclusions. The treatment with the IL-12 gene in the experimental HPV16-positive tumor model promoted the activation of the cellular immune response via expression of a Th1-type cytokine profile and was associated with the inhibition of tumor growth. Thus, IL-12 treatment represents a novel approach for gene therapy against cervical cancer.

STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer

“…Such NP‐mediated inhibition of self‐activation may have triggered the increased release of IL‐12 via NF‐κB and STAT3 downregulation (downregulation > switch of M2 towards M1 > reduced IL‐10 levels > inhibition of M2 autocrine activation by IL‐10 > high levels of IL‐12). IL‐12 is an important Th1 immune response mediator that exerts anti‐tumour activity through increased proliferation, survival, and/or cytotoxicity of NK cells, CD8, and CD4 T cells, as well as suppression of T reg activity (Garcia Paz et al, 2014; Zagozdzon & Lasek, 2016).…”

In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma

“…GM-CSF and IL-12 have been identified as promising cytokines for cancer immunotherapy, including treatment of melanoma; these cytokines activate antitumor immune cells and expand IFN- γ signaling through a positive-feedback loop. 46–49 …”

Functional genetic variability at promoters of pro‐(IL‐18) and anti‐(IL‐10) inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow‐up study

“…Our group has recently revealed the association of inflammatory levels with survival of tobacco exposed prostate cancer patients . It has been demonstrated that IL‐18 exerts anti‐tumor effects which are mediated by apoptosis induction and angiogenesis inhibition . Few other in vivo reports have also shown that IL‐18 has potent anti‐tumor effects when administered in animal models of lung cancer, lymphoma and melanoma .…”